SCHEMBL307516

SCHEMBL307516

CCCCCCCCCCCCCCCCCCCCCCCOc1ccccc1C=O

nearest known ligand 0.69

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 6/20 0.69
HTT P42858 2/20 0.69
HPGD P15428 1/20 0.69
SMN1; SMN2 Q16637 1/20 0.69
KMT2A Q03164 4/20 0.55
LMNA P02545 4/20 0.55
MEN1 O00255 3/20 0.55
MAPT P10636 2/20 0.55
NR1I2 O75469 1/20 0.55
CHRM2 P08172 1/20 0.55
CYP3A4 P08684 1/20 0.55
ADRA2A P08913 1/20 0.55
OPRK1 P41145 1/20 0.55
HTR2B P41595 1/20 0.55
SLC6A3 Q01959 1/20 0.55
HDAC6 Q9UBN7 1/20 0.55
PTGDR2 Q9Y5Y4 1/20 0.53
RAD52 P43351 1/20 0.51
GAA P10253 2/20 0.49
TDP1 Q9NUW8 1/20 0.49

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1509385 1.00 ALDH1A1 (0.69) ALDH1A1HTTHPGDSMN1; SMN2KMT2A
SCHEMBL8155524 1.00 ALDH1A1 (0.69) ALDH1A1HTTHPGDSMN1; SMN2KMT2A
SCHEMBL8453581 1.00 ALDH1A1 (0.69) ALDH1A1HTTHPGDSMN1; SMN2KMT2A
SCHEMBL1509382 1.00 ALDH1A1 (0.69) ALDH1A1HTTHPGDSMN1; SMN2KMT2A
SCHEMBL7830929 1.00 ALDH1A1 (0.69) ALDH1A1HTTHPGDSMN1; SMN2KMT2A
SCHEMBL1509367 1.00 ALDH1A1 (0.69) ALDH1A1HTTHPGDSMN1; SMN2KMT2A
SCHEMBL3432906 1.00 ALDH1A1 (0.69) ALDH1A1HTTHPGDSMN1; SMN2KMT2A
SCHEMBL1509387 1.00 ALDH1A1 (0.69) ALDH1A1HTTHPGDSMN1; SMN2KMT2A
SCHEMBL11369150 1.00 ALDH1A1 (0.69) ALDH1A1HTTHPGDSMN1; SMN2KMT2A
SCHEMBL28393449 1.00 ALDH1A1 (0.69) ALDH1A1HTTHPGDSMN1; SMN2KMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8092773-B2 Liquid fullerene derivative, method for producing the same, and device using the same NATIONAL INSTITUTE FOR MATERIALS SCIENCE (JP) 2012-01-10 US disclosed
US-20100019205-A1 Liquid Fullerene Derivative, Method for Producing the Same, and Device Using the Same NATIONAL INSTITUTE FOR MATERIALS SCIENCE (JP) 2010-01-28 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20100019205-A1 Liquid Fullerene Derivative, Method for Producing the Same, and Device Using the Same SCO2, RPLP2, MDM4 ALDH1A1 1665/4885HTT 1424/4885HPGD 2337/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.